Lawrence A. Kenyon, Executive Vice President, CFO and Interim CEO About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with ...

Project collaboration partner will have option to negotiate licensing and supply agreement ...

Microsoft has finally fixed a problem that causes Outlook to unexpectedly crash on Windows Server 2016 devices. The Current ...

In our Energy Outlook, we detail our forecasts on fossil fuel, renewables, carbon capture and storage, hydrogen, and utilities ...

Fintel reports that on January 21, 2025, Cantor Fitzgerald downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...